Biomia ApS
Private limited companyCVR 43616595København ØActive
Biomia ApS is a private limited company, based in København Ø, active in research and experimental development on natural sciences and engineering, founded in 2022. The company made a loss in both 2024 and 2025, most recently DKK 5.9m. Equity fell to DKK 5.5m in 2025.
Key figures · financial year 2025
What has changed
calculated from recorded figures and datesFinancials: 2025 against 2024
- The loss got smaller: from DKK 7.8m to DKK 5.9m (2024 → 2025).
- Equity fell 52% (2024 → 2025), to DKK 5.5m.
Employees
- 4 fewer employees than a year earlier: 4 (07/2026) against 8 (07/2025).
Management and owners, last 24 months
- New owners registered: Next Stage Ventures ApS (11/08/2026).
- No longer registered as owner: Next Stage Ventures ApS (10/08/2026) and Nucleus Capital I. Gmbh & Co KG (11/08/2026).
Registrations, last 24 months
- 11/08/2026: Share capital changed from 61,770 DKK to 63,010 DKK
- 12/02/2026: Share capital changed from 60,822 DKK to 61,770 DKK
- 27/01/2026: Share capital changed from 60,292 DKK to 60,822 DKK
- 01/01/2025: Industry changed to Research and experimental development on natural sciences and engineering (721000)
Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.
Financial statements
Financial years 2023–2025 · amounts in DKK thousandEquity and net profit
| 2023 | 2024 | 2025 | Change | |
|---|---|---|---|---|
| Revenue | not stated | not stated | not stated | – |
| Gross profit | −582 | −5,944 | −2,584 | +56.5% |
| Operating profit (EBIT) | −1,591 | −10,783 | −7,804 | +27.6% |
| Profit before tax | −1,200 | −10,213 | −7,863 | +23% |
| Net profit | −933 | −7,825 | −5,903 | +24.6% |
| Total assets | 19,636 | 15,547 | 8,312 | −46.5% |
| Equity | 19,185 | 11,360 | 5,456 | −52% |
| Liabilities | 451 | 4,187 | 2,842 | −32.1% |
| Cash and cash equivalents | 18,450 | 8,484 | 2,718 | −68% |
| Average number of employees | 1 | 5 | 6 | +20% |
Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2023, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.
Download the figures as CSV · free with an account, amounts in whole DKK
Signals from the financial statements
calculated from the 2025 figuresLoss for 3 years in a row
Net result has been negative in 2023–2025.
How is this calculated?
Net result is negative in the two or more latest annual reports in a row.
Equity fell sharply
Equity fell 52% from 2024 to 2025 (DKK 11.4m to DKK 5.5m).
How is this calculated?
Equity has fallen by at least 30% from the previous annual report, and it was positive the year before.
The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.
Annual reports
3 financial years| Financial year | Period | Published | Figures for | Documents |
|---|---|---|---|---|
| 2025 | 01/01/2025 – 31/12/2025 | 30/06/2026 | The company | PDF not statedXBRL |
| 2024 | 01/01/2024 – 31/12/2024 | 07/07/2025 | The company | PDFXBRL |
| 2023 | 31/10/2022 – 31/12/2023 | 23/05/2024 | The company | PDFXBRL |
The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.
Employees
monthly figures from CVRPosition in the industry
431 companies in the databaseComparison with the other companies in research and experimental development on natural sciences and engineering based on the latest financial year.
Industry median: gross profit DKK 616k, net profit −DKK 892k, equity DKK 2m, 5 employees.
Compared with similar companies
size, age and company form| Group | Gross profit | Equity |
|---|---|---|
| Companies with fewer than 20 employees69,967 companies in the comparison | No. 69,303of 69,742 Better than 1% | No. 13,369of 69,964 Better than 81% |
| Same industry and fewer than 20 employees329 companies in the comparison | No. 277of 323 Better than 14% | No. 92of 329 Better than 72% |
| Companies that are founded within the last five years16,662 companies in the comparison | No. 16,465of 16,614 Better than 1% | No. 1,222of 16,661 Better than 93% |
| All companies of type ApS66,508 companies in the comparison | No. 66,016of 66,379 Better than 1% | No. 10,568of 66,505 Better than 84% |
The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.
Compare with the industry
Research and experimental development on natural sciences and engineering- Biomia ApS−DKK 2.6m
- Carlsberg A/SDKK 40.2bn
- Zealand Pharma A/SDKK 9.2bn
- Biomia ApS−DKK 5.9m
- Carlsberg A/SDKK 7bn
- Zealand Pharma A/SDKK 6.5bn
- Biomia ApSDKK 5.5m
- Carlsberg A/SDKK 30.7bn
- Zealand Pharma A/SDKK 14.8bn
- Biomia ApS4
- Carlsberg A/S107
- Zealand Pharma A/S569
Latest financial year per company. Choose up to three companies from the largest in the industry.
Owners and group
from the Public Ownership Register- ZANDY Holding ApS15%
- iobio Holding ApS15%
- Keasling Biomanufacturing ApS5%
- LEGRAH Holdings ApS5%
- BY Capital 3 GmbH & Co. KG20%
- Amino Collective II GmbH & Co. KG5%
- Next Stage Ventures ApS10%
Management
3 active registrationsExecutive management
| Name | Role | Appointed |
|---|---|---|
| Michael Krogh Jensen | CEO | 31/10/2022 |
Board of directors
| Name | Role | Appointed |
|---|---|---|
| Henrik Stage | Chair of the board | 31/10/2022 |
| Michael Krogh Jensen | Board member | 02/08/2023 |
- Founders
- Next Stage Ventures ApS, CSS Invest ApS, ZANDY Holding ApS, iobio Holding ApS, Keasling Biomanufacturing ApS
Former management (2)
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| Jie Zhang | Board member | 31/10/2022 | 02/08/2023 |
| Jay D Keasling | Board member | 31/10/2022 | 02/08/2023 |
Signing rule: Selskabet tegnes af direktøren i forening med bestyrelsens formand, af direktøren i forening med et bestyrelsesmedlem, eller af den samlede bestyrelse.
Address and production units
1 active production unitsLersø Parkallé 44
2100 København Ø
København Municipality · Postcode 2100
Other companies at the address (1)
- Upsite ApSOther information technology and computer service activities
| Production unit | Address | Employees | P number |
|---|---|---|---|
| Biomia ApS | Lersø Parkallé 44, 3, 2100 København Ø | 4 | 1028712150 |
Purpose
Selskabets formål er at drive forskning og udvikling indenfor, og kommercialisering af, produktion af plantebaserede naturstoffer ved hjælp af bioteknologi.
The purpose is quoted from the register in Danish.
Changes year by year
32 registered events20267 changescapital 3 · ownership 3 · accounts 1
- CapitalShare capital changed from 61,770 DKK to 63,010 DKK
- OwnershipNext Stage Ventures ApS registered as owner (10%)
- OwnershipNUCLEUS CAPITAL I. GMBH & CO KG is no longer registered as owner
- OwnershipNext Stage Ventures ApS is no longer registered as owner
- AccountsAnnual report for 2025 published
- CapitalShare capital changed from 60,822 DKK to 61,770 DKK
- CapitalShare capital changed from 60,292 DKK to 60,822 DKK
20252 changesaccounts 1 · industry 1
- AccountsAnnual report for 2024 published
- IndustryIndustry changed to Research and experimental development on natural sciences and engineering (721000)
20241 changeaccounts 1
- AccountsAnnual report for 2023 published
202311 changesaddress 1 · capital 2 · ownership 5 · management 3
- AddressMoved to Lersø Parkallé 44, 3, 2100 København Ø
- CapitalShare capital changed from 53,333 DKK to 60,292 DKK
- OwnershipNUCLEUS CAPITAL I. GMBH & CO KG registered as owner (5%)
- OwnershipCSS Invest ApS is no longer registered as owner
- OwnershipAmino Collective II GmbH & Co. KG registered as owner (5%)
- CapitalShare capital changed from 40,000 DKK to 53,333 DKK
- ManagementMichael Krogh Jensen appointed board member
- ManagementJie Zhang stepped down as board member
- ManagementJay D Keasling stepped down as board member
- OwnershipBY Capital 3 GmbH & Co. KG registered as owner (20%)
- OwnershipLEGRAH Holdings ApS registered as owner (5%)
202211 changesaddress 1 · founded 1 · management 4 · ownership 5
- AddressMoved to Kemitorvet 220, 2800 Kongens Lyngby
- FoundedRegistered as Biomia ApS
- ManagementJie Zhang appointed board member
- ManagementJay D Keasling appointed board member
- ManagementHenrik Stage appointed chair of the board
- ManagementMichael Krogh Jensen appointed ceo
- OwnershipKeasling Biomanufacturing ApS registered as owner (5%)
- OwnershipCSS Invest ApS registered as owner (5%)
- OwnershipZANDY Holding ApS registered as owner (15%)
- Ownershipiobio Holding ApS registered as owner (15%)
- OwnershipNext Stage Ventures ApS registered as owner (5%)
Related companies
Same industry in København
- Genmab A/S676 employees
- 3shape A/S518 employees
- Carlsberg A/S107 employees
- IQVIA RDS Denmark A/S100 employees
- Nuevolution A/S100 employees
- Sunshine Enterprise Holding A/S73 employees
Same people in management
- Adcendo ApSvia Henrik Stage
- Skape Bio ApSvia Henrik Stage
- Synact Pharma ApSvia Henrik Stage
- Fuse Vectors ApSvia Henrik Stage
- ResoTher Pharma A/Svia Henrik Stage
- iNotify ApSvia Henrik Stage
Largest in the industry
- Carlsberg A/SDKK 40.2bn
- Zealand Pharma A/SDKK 9.2bn
- Gubra A/SDKK 2.6bn
- Vestas Wind Systems A/SDKK 2.5bn
- Bang & Olufsen A/SDKK 1.4bn
- 3shape A/SDKK 1.3bn
Source and updates
The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.